MoonLake Immunotherapeutics (MLTX) Total Liabilities (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Total Liabilities of $146.4 million for Q1 2026, up 48.31% year-over-year from $98.7 million in Q1 2025, and up 22.01% quarter-over-quarter from $120.0 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Total Liabilities (2020 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $146.4 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 48.31% year-over-year to $146.4 million; the TTM figure through Mar 2026 stood at $146.4 million (up 48.31% YoY), while the FY2025 annual figure was $120.0 million, up 388.76% from the prior year.
- Total Liabilities for Q1 2026 stood at $146.4 million, up from $120.0 million in the prior quarter.
- The five-year high for Total Liabilities was $206.8 million in Q1 2022, with the low at $3.9 million in Q2 2022.
- The 5-year median for Total Liabilities is $14.8 million (2024), against an average of $54.6 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 4962.8% in 2022, then tumbled 96.28% in 2023.
- MoonLake Immunotherapeutics' Total Liabilities stood at $8.1 million in 2022, then surged by 61.57% to $13.0 million in 2023, then surged by 88.07% to $24.5 million in 2024, then surged by 388.76% to $120.0 million in 2025, then advanced by 22.01% to $146.4 million in 2026.
- Business Quant data shows MLTX's Total Liabilities at $146.4 million in Q1 2026, $120.0 million in Q4 2025, and $123.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | 145.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.75 Mn |
| Mar 31, 2026 | 146.35 Mn |
| Dec 31, 2025 | 119.95 Mn |
| Sep 30, 2025 | 123.14 Mn |
| Jun 30, 2025 | 102.15 Mn |
| Mar 31, 2025 | 98.68 Mn |
| Dec 31, 2024 | 24.54 Mn |
| Sep 30, 2024 | 22.71 Mn |
| Jun 30, 2024 | 14.85 Mn |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 13.05 Mn |
| Sep 30, 2023 | 10.58 Mn |
| Jun 30, 2023 | 7.51 Mn |
| Mar 31, 2023 | 7.68 Mn |
| Dec 31, 2022 | 8.08 Mn |
| Sep 30, 2022 | 6.02 Mn |
| Jun 30, 2022 | 3.88 Mn |
| Mar 31, 2022 | 206.82 Mn |
| Dec 31, 2021 | 21.33 Mn |
| Sep 30, 2021 | 6.08 Mn |